Efficacy and Safety of Recombinant Human Prourokinase in Acute Ischemic Stroke Within 4.5 h: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Efficacy and Safety of Recombinant Human Prourokinase in Acute Ischemic Stroke Within 4.5 h: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

<h3>Background</h3><p dir="ltr">Acute ischemic stroke (AIS) requires timely thrombolysis to restore perfusion and minimize neurological damage. Recombinant human prourokinase (rhPro‐UK) has emerged as a promising alternative to alteplase, with potential efficacy and safet...

Full description

Saved in:
Bibliographic Details
Main Author: Muhammad Hassan Waseem (22392178) (author)
Other Authors: Zain Ul Abideen (1410154) (author), Aiman Waheed (22392181) (author), Hafsa Arshad Azam Raja (20151441) (author), Sanan Rasheed (22392184) (author), Muhammad Mukhlis (22392187) (author), Muhammad Abdullah Ali (21409807) (author), Marium Khan (5125439) (author), Umama Alam (21761273) (author), Muhammad Fawad Tahir (22073279) (author), Javed Iqbal (2121922) (author), Ubaid Farooq (22392190) (author), Sania Aimen (22392193) (author)
Published: 2025
Subjects:
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Neurosciences
alteplase
ischemic stroke
meta-analysis
recombinant human prourokinase
systematic review
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items